WCN25-1613 GLUCOCORTICOID TOXICITY INDEX IN MEMBRANOUS NEPHROPATHY AND PODOCYTOPATHIES IN ADULT: A PILOT STUDY

WCN25-1613 GLUCOCORTICOID TOXICITY INDEX IN MEMBRANOUS NEPHROPATHY AND PODOCYTOPATHIES IN ADULT: A PILOT STUDY

Saved in:

Bibliographic Details
Main Authors:	RAJESH KUMAR, Sanjay Bhadada, Abhishek Ghosh, Basavaraj Tigari, Harbir singh kohli, Raja Ramachandran
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924030419
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-4036 Improved Outcomes with an Additional Rituximab Dose in Primary Membranous Nephropathy
by: Vinod Kumar, et al.
Published: (2025-02-01)

WCN24-2478 PODOCYTOPATHY ASSOCIATED WITH IGA NEPHROPATHY: IS IT REALLY A PROGNOSTIC FACTOR?
by: BELENGALLEGOS VAZQUEZ, et al.
Published: (2024-04-01)

WCN24-802 ALPORT SYNDROME WITH PODOCYTOPATHY
by: NIHAL BASHIR, et al.
Published: (2024-04-01)

WCN24-1436 COLLAPSING LUPUS PODOCYTOPATHY, UNLIKE OTHER COLLAPSING GLOMERULOPATHIES?
by: Elisa Mendoza, et al.
Published: (2024-04-01)

WCN25-4091 OUTCOME OF PRIMARY MEMBRANOUS NEPHROPATHY IN DIABETIC AND NON-DIABETIC PATIENTS: A RETROSPECTIVE OBSERVATIONAL STUDY
by: ELSA THOMAS, et al.
Published: (2025-02-01)

Non-invasive Diagnosis of Antinephrin–Associated Podocytopathy
by: Felicitas E. Hengel, et al.
Published: (2025-08-01)

Clinical efficacy of tacrolimus combined with glucocorticoids for idiopathic membranous nephropathy
by: LING Yi-sheng, et al.
Published: (2016-01-01)

Efficacy of tacrolimus or cyclophosphamide combined with glucocorticoids in the treatment of idiopathic membranous nephropathy
by: MAO Wen-li, et al.
Published: (2018-01-01)

WCN25-1092 A STUDY OF CLINICOPATHOLOGICAL SPECTRUM AND OUTCOME OF PRIMARY MEMBRANOUS NEPHROPATHY
by: Muzamil ahmad wani, et al.
Published: (2025-02-01)

WCN25-3843 IT IS NOT ALWAYS DIABETIC NEPHROPATHY: A CASE REPORT OF FIBRILLARY GLOMERULONEPHRITIS
by: Reima Almarshoodi, et al.
Published: (2025-02-01)

Complement and Podocytopathies: Do We Have a New Biomarker?
by: Miquel Blasco, et al.
Published: (2024-03-01)

THE POLICY OF THE RUSSIAN STATE IN THE NORTH CAUCASUS IN THE PERIOD GOVERNMENT OF FIRST ROMANOV (1613-1645)
by: Aleksandr A. Kudryavcev, et al.
Published: (2022-05-01)

WCN25-1585 A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN)
by: Jonathan Barratt, et al.
Published: (2025-02-01)

Glucocorticoid toxicity index in patients with systemic lupus erythematosus (preliminary data)
by: E. V. Ermolaeva, et al.
Published: (2024-02-01)

WCN25-4235 CHRONICITY SCORE AND NOT MEST C SCORE IS A BETTER PREDICTOR OF PROGNOSIS IN IGA NEPHROPATHY
by: TULSI MODI, et al.
Published: (2025-02-01)

WCN25-4604 EXOME ANALYSIS POINTS APOE4 HAPLOTYPE AS MAJOR RISK TO DEVELOP MESOAMERICAN NEPHROPATHY
by: Iván Landires, et al.
Published: (2025-02-01)

Minimal Change Podocytopathy with Coexistent Thin Glomerular Basement Membrane following Exposure to Semaglutide
by: Karthik Kovvuru, et al.
Published: (2025-01-01)

Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies
by: Maxime Teisseyre, et al.
Published: (2025-03-01)

Passion et néostoïcisme dans The Revenge of Bussy D’Ambois (1613) de George Chapman (1559 ?-1634)
by: Gilles Bertheau
Published: (2002-05-01)

WCN24-1061 ACUTE INTERSTITIAL NEPHROPATHY: CLINICAL-HISTOLOGICAL AND THERAPEUTIC ASPECTS
by: Nermine Ben Achour, et al.
Published: (2024-04-01)

WCN25-4065 EVALUATING PLATELET INFLAMMATORY MARKERS AS DIAGNOSTIC TOOLS FOR DIFFERENTIATING PROTEINURIC AND NON-PROTEINURIC VARIATIONS OF DIABETIC NEPHROPATHY
by: Surya Shanbhog, et al.
Published: (2025-02-01)

Features of toxic nephropathy development during antibiotic therapy
by: R. E. Kazakov, et al.
Published: (2023-12-01)

WCN25-1780 ULTRASTRUCTURAL CHARECTORISTICS OF DIABETIC NEPHROPATHY AND ITS PREDICTIVE ROLE IN ASSESSING DISEASE PROGRESSION: A RETROSPECTIVE COHORT STUDY
by: sonu manuel, et al.
Published: (2025-02-01)

WCN25-52 EPIDEMIOLOGY OF IMMUNOGLOBULIN A NEPHROPATHY (IgAN) AND OCCURRENCE OF PROTEINURIA IN CHINA: EVIDENCE FROM SYSTEMATIC REVIEW AND META-ANALYSIS
by: Zhaoxin Chen, et al.
Published: (2025-02-01)

Urinary Soluble CD163: A Novel Biomarker Suggests Who Should Receive Glucocorticoids in IgA Nephropathy
by: Guisen Li, et al.
Published: (2024-10-01)

WCN25-336 A CAPTIVATING CASE OF NEURAL EPIDERMAL GROWTH FACTOR-LIKE 1 PROTEIN (NELL-1) ASSOCIATED MEMBRANOUS NEPHROPATHY
by: Satyanand Sathi, et al.
Published: (2025-02-01)

WCN25-4226 DYNAMIC INSIGHTS INTO THERAPEUTIC STRATEGIES AND LONGITUDINAL OUTCOMES: A RETROSPECTIVE ANALYSIS OF NELL1 POSITIVE MEMBRANOUS NEPHROPATHY COHORT
by: GURJOT SINGH, et al.
Published: (2025-02-01)

WCN24-1863 Towards an IgA Nephropathy Atlas
by: Julio Saez-Rodriguez, et al.
Published: (2024-04-01)

WCN24-1766 EFFECTS OF DAPAGLIFLOZIN IN PATIENTS WITH MEMBRANOUS NEPHROPATHY
by: Hiddo J.L. Heerspink, et al.
Published: (2024-04-01)

Clinical Characteristics and Outcomes of Neural Epidermal Growth Factor-like 1 Protein-Associated Membranous Nephropathy
by: Suruthy Narayanasami, et al.
Published: (2024-05-01)

WCN25-4499 Collagenofibrotic glomerulopathy – a rare cause of Nephrotic range proteinuria
by: SRISHTI RATHI, et al.
Published: (2025-02-01)

WCN25-4233 THE FITNESS PARADOX
by: Swetha rajkumar, et al.
Published: (2025-02-01)

WCN25-4041 A rare case of large sub serosal fibroid associated with ADPKD
by: Gita Bipin Chandra, et al.
Published: (2025-02-01)

WCN24-186 JAK/STAT EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY
by: Mateus Luvizotto, et al.
Published: (2024-04-01)

WCN24-2271 WARFARINRELATED NEPHROPATHY IN TWO PATIENTS WITH MECHANICAL VALVES
by: Hong Cheng, et al.
Published: (2024-04-01)

WCN25-2030 RENAL TUBERCULOSIS MIMICKING GRAFT REJECTION : A DIAGNOSTIC CHALLENGE
by: Pavan Wakhare, et al.
Published: (2025-02-01)

WCN25-270 POSTPARTUM RENAL CORTICAL NECROSIS IS ASSOCIATED WITH DISTINCT THROMBOTIC MICROANGIOPATHY SYNDROME
by: Adarsh Kumar, et al.
Published: (2025-02-01)

WCN25-25 PEDIATRIC KIDNEY TRANSPLANTATION IN THE MIDDLE EAST: CHALLENGES AND SOLUTIONS
by: Mohamad Bassam Said
Published: (2025-02-01)

Selective glucocorticoid receptor agonists as an alternative to glucocorticoids in the treatment of acute lymphoblastic leukemia: clinical response to glucocorticoids compared with molecular effects <i>in vitro</i>
by: O. A. Vlasova, et al.
Published: (2025-05-01)

WCN25-1553 EFFICACY AND SAFETY OF DAILY ORAL STEROID AND CYCLOPHOSPHAMIDE VERSUS CYCLICAL STEROID AND CYCLOPHOSPHAMIDE IN ADULT PATIENTS WITH MEMBRANOUS NEPHROPATHY :A RANDOMIZED CONTROLLED TRIAL
by: Paromita Das, et al.
Published: (2025-02-01)